Eur Rev Med Pharmacol Sci 2021; 25 (20): 6174-6175
DOI: 10.26355/eurrev_202110_26986

Letter to Editor on the paper entitled “Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer”

I. Giacomini, V. Quagliariello, E. Ragazzi, M. Montopoli

Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy. monica.montopoli@unipd.it

Free PDF Download

To cite this article

I. Giacomini, V. Quagliariello, E. Ragazzi, M. Montopoli
Letter to Editor on the paper entitled “Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer”

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 20
Pages: 6174-6175
DOI: 10.26355/eurrev_202110_26986

Keywords Related articles:

  1. Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer
  2. Letter to editor on the paper entitled “Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19”
  3. Letter to editor, in response to paper entitled “Side effects after COVID-19 vaccinations among residents of Poland”
  4. Letter to the Editor – DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer
  5. Letter to editor, in response to letter entitled: Could monitoring normotensives delay progression to hypertension?